Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.

The residential cruise ship from Storylines aims to become the world’s first "blue zone" at sea by taking a holistic approach ...

The growing incidence of genetic disorders and chronic illnesses, including cancer and rare inherited conditions, is fueling the demand for advanced therapies, highlighting the need for strong ...

Researchers identified a gene that seems to help slow brain aging in women, and studied links between hormone therapy, ...

New genetic therapy has brought “life-changing improvements” in the vision of the infants born with one of the most severe forms of childhood blindness.According to Kings College London, an ...

Childs Cure co-founders Jainu and Shruti Jogani founded the organization to address the genetic causes of rare diseases, ...

In this week’s InnovationRx newsletter, tariffs could hit medical devices, a gene therapy company that helps blind kids see ...

Hearing impairment affects millions globally, with genetics playing a major role in infant hearing loss. Early screening and ...

The FDA has accepted for Priority Review the BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis.

Opus Genetics (IRD) announced that three abstracts on its investigational gene therapy candidates have been accepted for presentation at the ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

OPGx-MERTK is a gene therapy being developed by Opus Genetics to treat patients impacted by MERTK-related retinitis pigmentosa (RP). Results from a pre-clinical study which evaluated OPGx-MERTK in a ...